Sarthak Sahoo

CV Raman Rd
Bengaluru, KA 560012, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 55 publications

Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancer.

Endocrine therapy-specific lineage and partial epithelial-mesenchymal reprogramming defines divergent resistant cell-states in ER+ breast cancer.

Journal: bioRxiv : the preprint server for biology

Published: May 25, 2026

CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy.

CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy.

Journal: Cancer research communications

Published: April 22, 2026

Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition.

Systems-level analysis identifies IRF6 as an inhibitor of epithelial-mesenchymal transition.

Journal: Journal of biological engineering

Published: January 31, 2026

Multi-omics investigation reveals molecular determinants of cancer cell evolution on soft extracellular matrix.

Multi-omics investigation reveals molecular determinants of cancer cell evolution on soft extracellular matrix.

Journal: bioRxiv : the preprint server for biology

Published: December 25, 2025

Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.

Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 19, 2025

Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.

Regulatory network and spatial modeling reveal cooperative mechanisms of resistance and immune escape in ER+ breast cancer.

Journal: BMC cancer

Published: October 01, 2025

Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

Blockade of Tumor-Intrinsic TGFβ Signaling Drives Hyperprogression in Small Cell Lung Cancer.

Journal: Cancer discovery

Published: August 21, 2025

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

Low-GPX4 drives a sustained drug-tolerant persister state in TNBC by a targetable adaptive FSP1 upregulation.

Journal: Redox biology

Published: July 19, 2025

CD4+ T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapy.

CD4+ T-cells sensitize quasi-mesenchymal breast tumors lacking CD73 to anti-CTLA4 immune checkpoint blockade therapy.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

An integrative molecular systems approach unravels mechanisms underlying biphasic nitrate uptake by plant nitrate transporter NRT1.1.

An integrative molecular systems approach unravels mechanisms underlying biphasic nitrate uptake by plant nitrate transporter NRT1.1.

Journal: NPJ systems biology and applications

Published: March 25, 2025

Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition.

Anoikis resistance and metastasis of ovarian cancer can be overcome by CDK8/19 mediator kinase inhibition.

Journal: JCI insight

Published: February 20, 2025

Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis.

Bioenergetic reprogramming of macrophages reduces drug tolerance in Mycobacterium tuberculosis.

Journal: Nature communications

Published: February 03, 2025

Showing 1-12 of 55

Last Updated: 09/26/2026